Prospective study of Grazoprevir and Elbasvir for HCV genotype 1 intected Japanese patients
Not Applicable
- Conditions
- HCV genotype 1 infected chronic liver disease
- Registration Number
- JPRN-UMIN000025191
- Lead Sponsor
- Osaka City University and affiliated hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 119
Inclusion Criteria
Not provided
Exclusion Criteria
Pregnant woman Decompensated cirrhosis hepatocellular carcinoma Doctors judge as inappropriate
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Sustained viral response (12 weeks post-treatment)
- Secondary Outcome Measures
Name Time Method Regression rate of liver fibrosis Suppressive effect on HCC incidence